Ochsner Health in New Orleans is one of two sites in Louisiana and among 120 across the globe participating in a COVID-19 vaccine study conducted by Pfzer Inc. and BioNTech SE. There will collectively be up to 30,000 participants in the study led by Julia Garcia-Diaz, an infectious disease specialist and Ochsner Health's director of clinical infectious diseases.